Veterinary Medicines

L-Spec 50/100 mg/ml oldatos injekció A.U.V.

Authorised
  • Lincomycin hydrochloride
  • Spectinomycin dihydrochloride pentahydrate
Download as PDF

Product identification

Medicine name:
L-Spec 50/100 mg/ml oldatos injekció A.U.V.
Active substance:
  • Lincomycin hydrochloride
  • Spectinomycin dihydrochloride pentahydrate
Target species:
  • Cattle
  • Sheep
  • Goat
  • Pig
  • Dog
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Spectinomycin dihydrochloride pentahydrate
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        21
        day
    • Sheep
      • Meat and offal
        21
        day
    • Goat
      • Meat and offal
        21
        day
    • Pig
      • Meat and offal
        21
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Available in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."